Zantac and Cancer

I have been approached by a law firm to share their concerns about Zantac. If anyone wishes to have more information they should contact the legal firm directly:

Hi Jonathan,

My name is Courtney, I’m part of the Community Outreach team for Florin|Roebig, our firm has a long history of promoting and educating the public on issues of social justice and public safety. Because of our passion for community involvement, we wanted to use our experience and gathered knowledge to create informational resources.

Late 2019, FDA released a statement alerting patients and healthcare providers of a safety concern regarding the drug, ranitidine, commonly bought under the brand name, Zantac. The test findings demonstrating toxic levels of a carcinogenic ingredient known as NDMA.

Personal injury lawsuits claim these drug makers marketed and sold drugs contaminated with toxic amounts of NDMA, without disclosing the health risks, such as cancer-causing effects, to the government or the public. Because of this, people across the US have joined lawsuits against Zantac.

Consumers and their loved ones are understandably concerned about the recent statements. It’s important to make this information much more accessible than it’s been in the past. In this guide,, we touch on points such as:

  • Increased Risk For Kidney Cancer
  • How Can NDMA Affect The Kidneys?
  • What To Do About A Kidney Cancer Diagnosis
  • & much more.

Perhaps you’d be interested in checking it out and sharing it as a resource? I look forward to hearing back from you!

Courtney Collins
Outreach Specialist
Florin | Roebig Trial Attorneys

Leave a Reply

Your email address will not be published. Required fields are marked *